Oct 29, 2026 earnings call — Titan XT and OmniSphere refresh momentum
Omnicell reported total revenue of $308 million and non-GAAP EBITDA of $45 million, both above the high end of prior guidance.
Revenue $0.3B (est $0.3B) · EPS $0.58 (est $0.42) · Next-quarter revenue outlook $0.3B–$0.3B
Key quotes
"We're just days away from the first shipment of Titan XT hardware, consistent with the second half 2026 timing we outlined at the start of the year, and we continue to target the first half of 2027 for general availability of OmniSphere."
"As a reminder, we continue to expect our full-year 2026 bookings to be back-end weighted, consistent with the guidance range we provided last quarter."
"Our EBITDA is growing meaningfully faster than revenue this year, even as top-line growth remains modest, which we note is a natural feature of where we are in the early stages of the refresh cycle."
Analyst Q&A 8
Bookings outlook and timing
Q (Stan Berenshteyn · Wells Fargo): He asked what would drive reaching the high or low end of bookings guidance for the year. He also asked whether the $135 million that might not hit this year would fall into 2027 or be timing uncertain.
A: Management said they see two tracks of customer conversations: upgrades within the XT install base and competitive opportunities, and those conversations are getting deeper and closer to decisions. They reiterated that product bookings are back-end-of-year weighted and that timing and binary outcomes of competitive deals make near-term booking timing variable; the low end of 2026 product bookings guidance remains $425 million.
"As a reminder for investors, the low end of our 2026 product bookings guidance remains $425 million, and we reconfirm that range that we shared last quarter." — Baird Radford (CFO)
Lease vs purchase mix and margins
Q (Jessica Tassan · Piper Sandler): She asked what mix of leased versus purchased cabinets to expect in 2026 bookings. She also asked how lease economics differ from a purchased cabinet in the implementation year on revenue and gross margin.
A: Management said leasing helps keep Omnicell competitive and opens conversations to focus on clinical outcomes rather than price. They expect leasing to be slow and possibly lumpy, estimate somewhere around 30-ish percent of the marketplace is actively involved in leasing (mostly competitor customers), and said leases are structured as sales-type leases so revenue is treated upfront like a capital sale but with a slight gross-margin erosion at implementation and interest revenue recognized over the lease life.
"The structure of the lease is set up, without being too wonky, as a sales-type lease, so revenue is treated upfront similar to a capital sale." — Baird Radford (CFO)
Titan XT timing and pipeline mix
Q (Allen Lutz · BofA): He asked how 3Q bookings compared to expectations and how much of the $135 million fourth-quarter product bookings range is Titan XT. He also asked how the product mix in the pipeline has shifted recently.
A: Management said Titan XT shipments are just starting and revenue to date has not been Titan XT, so only a modest amount of Titan XT revenue is expected this year. They reiterated bookings are back-end weighted and variable, and they are talking across the spectrum to competitor customers and to XT install-base customers who may add cabinets or do refreshes.
"The implication here is the revenue to date has not been Titan XT." — Nnamdi Njoku (COO)
OmniSphere subscription length
Q (Talef Corman · Craig-Hallum): He asked what subscription length customers prefer for OmniSphere.
A: Management said they are still testing subscription durations but the subscription model resonates because it gives customers visibility into total cost of ownership and lets them titrate up or down as their asset footprint changes. They said duration will likely vary by customer based on financial needs, will evolve over time, and they will share more as they reach GA.
"A big part of why customers are responding to that is the conversation around total cost of ownership." — Nnamdi Njoku (COO)
Is OmniSphere in the $2.5B and size
Q (David Larsen · BTIG): He asked whether OmniSphere revenue is included in the cited $2.5 billion opportunity and, if not, how much incremental revenue OmniSphere could generate and over what timeframe.
A: Management said the enterprise sales conversation is for the full package of hardware plus OmniSphere, but their original in-excess-of-$2.5 billion opportunity for Titan XT was hardware only and did not include OmniSphere or market-share gains. They said OmniSphere monetization is a multi-year journey aligned to the hardware refresh, that customers moving to the cloud can use console upgrades, and they will not disclose OmniSphere market size today.
"Our original in excess of $2.5 billion opportunity for Titan XT was hardware only." — Baird Radford (CFO)
Why Q4 product revenue moved down
Q (Scott Schoenhaus · KeyBanc): He asked what drove the roughly $10 million midpoint downward revision in fourth-quarter product revenue guidance. He wanted to know if it was due to implementation schedules, one large customer, many customers, or competitive conversions.
A: Management said the revised Q4 guide still leaves full-year results within the original range but toward the lower end, and the sequential decline is not driven by any single customer but by limited scheduling visibility with two months left in the year. They also said back-end-weighted bookings reduce in-year conversions, Titan XT shipment timing and prior customer scheduling choices affect Q4, and competitive wins commonly take 9 to 12 months to convert to revenue so would show up next year.
"By that I mean it's not a singular customer, it's not a dynamic of the competitive environment." — Baird Radford (CFO)
Lease customers and win rates versus history
Q (Gene Mannheimer · Freedom): He asked whether lease conversations are concentrated with smaller health systems and whether competitive win rates will be very different versus the prior XT refresh cycle.
A: Management said they have had a history of market share gains, noted they now have two new systems in the market, and pointed out their systems are on average younger than competitor systems which creates more competitive activity. They said many dynamics affect how share evolves and that customer prioritization makes it hard to call win rates precisely, though they are confident in their conversations.
"We know that our systems are on average younger than our competitor systems." — Nnamdi Njoku (COO)
Sequential margin change and outlook
Q (Bill Sutherland · StoneX): He asked for more color on the sequential margin change from 3Q to 4Q and what that may imply for future margin expectations.
A: Management said Q2 included almost a $15 million one-time tariff refund that should be removed when modeling margins, that Q3 showed a favorable product and customer mix (after adjusting Q2), and that memory and component cost pressure is a headwind of roughly $6 million in the second half which they expect to continue. They advised investors to remove the tariff benefit and to anticipate ongoing memory costs; Randall added qualitative comments about strong market interest, growing pipeline, and the upcoming Titan XT shipment.
"First, the Q2 gross margin reflects almost a $15 million one-time benefit from tariff refunds." — Baird Radford (CFO)